NCT06611007View on ClinicalTrials.gov

Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

July 15, 2028

Study Completion Date

July 15, 2028

Conditions
Osteoarthritis
Interventions
DRUG

embolization therapy

Hand arterial embolization with Lipiodol in emulsion with iodinated contrast agent

Trial Locations (1)

38130

RECRUITING

CHU Grenoble Alpes - Sud site, Échirolles

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT06611007 - Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment | Biotech Hunter | Biotech Hunter